OIX CARE: INTEGRATED AND FULLY AUTOMATED ECOSYSTEM TO SUPPORT THE MANAGEMENT OF PATIENTS WITH DEMENTIA (Q4193221): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: Setting new description) |
(Changed label, description and/or aliases in en, and other parts: Adding English translations) |
||||||||||||||
| label / en | label / en | ||||||||||||||
OIX CARE: INTEGRATED AND FULLY AUTOMATED ECOSYSTEM TO SUPPORT THE MANAGEMENT OF PATIENTS WITH DEMENTIA | |||||||||||||||
| Property / summary | |||||||||||||||
OIX CARE Ê A SOLUTION, DEVELOPED BY AVANIX SRL, TO SUPPORT CAREGIVERs’ MANAGEMENT OF PATIENTS WITH DEMENTIA. IT IS THE FIRST INTEGRATED AND AUTOMATED ECOSYSTEM THAT ALLOWS YOU TO MONITOR THE ACTIVITY AND MOVEMENT OF THE PATIENT AND ALERT YOUR CAREGIVER IN CASE OF ABNORMALITIES. OIX CARE STANDS OUT FROM COMPETING TECHNOLOGIES IN THAT IT IS A WEARABLE DEVICE TOLERATED BY THE PATIENT, WORKS OVER MEDIUM-LARGE DISTANCES BOTH INDOORS AND OUTDOORS, WORKS EVEN IN THE ABSENCE OF A NETWORK CONNECTION, FULLY AUTOMATED AND EASY TO USE. BY 2025, AVANIX AIMS TO SELL 75,000 OIX CARE SYSTEMS WORLDWIDE AND GENERATE REVENUES OF ÂEUR 23.8 MILLION. AVANIX’S SOLUTION WILL SIGNIFICANTLY CONTRIBUTE TO THE WELFARE OF CAREGIVERS, AND TO AN ANNUAL COST SAVINGS RELATED TO THEIR ACTIVITY TO SUPPORT THE SICK. AFTER A TEST PHASE, AVANIX WILL START PRODUCTION OF OIX CARE IN THE FOURTH QUARTER OF 2019. AVA TEAM (English) | |||||||||||||||
| Property / summary: OIX CARE Ê A SOLUTION, DEVELOPED BY AVANIX SRL, TO SUPPORT CAREGIVERs’ MANAGEMENT OF PATIENTS WITH DEMENTIA. IT IS THE FIRST INTEGRATED AND AUTOMATED ECOSYSTEM THAT ALLOWS YOU TO MONITOR THE ACTIVITY AND MOVEMENT OF THE PATIENT AND ALERT YOUR CAREGIVER IN CASE OF ABNORMALITIES. OIX CARE STANDS OUT FROM COMPETING TECHNOLOGIES IN THAT IT IS A WEARABLE DEVICE TOLERATED BY THE PATIENT, WORKS OVER MEDIUM-LARGE DISTANCES BOTH INDOORS AND OUTDOORS, WORKS EVEN IN THE ABSENCE OF A NETWORK CONNECTION, FULLY AUTOMATED AND EASY TO USE. BY 2025, AVANIX AIMS TO SELL 75,000 OIX CARE SYSTEMS WORLDWIDE AND GENERATE REVENUES OF ÂEUR 23.8 MILLION. AVANIX’S SOLUTION WILL SIGNIFICANTLY CONTRIBUTE TO THE WELFARE OF CAREGIVERS, AND TO AN ANNUAL COST SAVINGS RELATED TO THEIR ACTIVITY TO SUPPORT THE SICK. AFTER A TEST PHASE, AVANIX WILL START PRODUCTION OF OIX CARE IN THE FOURTH QUARTER OF 2019. AVA TEAM (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: OIX CARE Ê A SOLUTION, DEVELOPED BY AVANIX SRL, TO SUPPORT CAREGIVERs’ MANAGEMENT OF PATIENTS WITH DEMENTIA. IT IS THE FIRST INTEGRATED AND AUTOMATED ECOSYSTEM THAT ALLOWS YOU TO MONITOR THE ACTIVITY AND MOVEMENT OF THE PATIENT AND ALERT YOUR CAREGIVER IN CASE OF ABNORMALITIES. OIX CARE STANDS OUT FROM COMPETING TECHNOLOGIES IN THAT IT IS A WEARABLE DEVICE TOLERATED BY THE PATIENT, WORKS OVER MEDIUM-LARGE DISTANCES BOTH INDOORS AND OUTDOORS, WORKS EVEN IN THE ABSENCE OF A NETWORK CONNECTION, FULLY AUTOMATED AND EASY TO USE. BY 2025, AVANIX AIMS TO SELL 75,000 OIX CARE SYSTEMS WORLDWIDE AND GENERATE REVENUES OF ÂEUR 23.8 MILLION. AVANIX’S SOLUTION WILL SIGNIFICANTLY CONTRIBUTE TO THE WELFARE OF CAREGIVERS, AND TO AN ANNUAL COST SAVINGS RELATED TO THEIR ACTIVITY TO SUPPORT THE SICK. AFTER A TEST PHASE, AVANIX WILL START PRODUCTION OF OIX CARE IN THE FOURTH QUARTER OF 2019. AVA TEAM (English) / qualifier | |||||||||||||||
point in time: 31 January 2022
| |||||||||||||||
Revision as of 18:52, 31 January 2022
Project Q4193221 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | OIX CARE: INTEGRATED AND FULLY AUTOMATED ECOSYSTEM TO SUPPORT THE MANAGEMENT OF PATIENTS WITH DEMENTIA |
Project Q4193221 in Italy |
Statements
15,000.0 Euro
0 references
30,000.0 Euro
0 references
50.0 percent
0 references
AVANIX S.R.L.
0 references
OIX CARE Ê UNA SOLUZIONE, SVILUPPATA DA AVANIX SRL, PER SUPPORTARE LA GESTIONE DEI PAZIENTI CON DEMENZA DA PARTE DEI CAREGIVER. à IL PRIMO ECOSISTEMA INTEGRATO E AUTOMATIZZATO CHE CONSENTE DI MONITORARE L'ATTIVITà E IL MOVIMENTO DEL PAZIENTE E DI ALLERTARE IL PROPRIO CAREGIVER IN CASO DI ANOMALIE. OIX CARE SI DISTINGUE DALLE TECNOLOGIE CONCORRENTI IN QUANTO Ê UN DISPOSITIVO INDOSSABILE TOLLERATO DAL PAZIENTE, FUNZIONA SU DISTANZE MEDIO-GRANDI SIA IN AMBIENTI CHIUSI CHE ALL'ESTERNO, FUNZIONA ANCHE IN ASSENZA DI UNA CONNESSIONE DI RETE, Ê COMPLETAMENTE AUTOMATIZZATO ED Ê FACILE DA USARE. ENTRO IL 2025, AVANIX PUNTA A VENDERE 75.000 SISTEMI OIX CARE IN TUTTO IL MONDO E GENERARE RICAVI PER  23,8 MILIONI. LA SOLUZIONE DI AVANIX CONTRIBUIRà IN MODO SIGNIFICATIVO AL BENESSERE DEI CAREGIVER, E AD UN RISPARMIO ANNUALE DI SPESA CORRELATA ALLA LORO ATTIVITà DI SUPPORTO AL MALATO. DOPO UNA FASE DI TEST, AVANIX INIZIERà LA PRODUZIONE DI OIX CARE NEL QUARTO TRIMESTRE DEL 2019. IL TEAM AVA (Italian)
0 references
OIX CARE Ê A SOLUTION, DEVELOPED BY AVANIX SRL, TO SUPPORT CAREGIVERs’ MANAGEMENT OF PATIENTS WITH DEMENTIA. IT IS THE FIRST INTEGRATED AND AUTOMATED ECOSYSTEM THAT ALLOWS YOU TO MONITOR THE ACTIVITY AND MOVEMENT OF THE PATIENT AND ALERT YOUR CAREGIVER IN CASE OF ABNORMALITIES. OIX CARE STANDS OUT FROM COMPETING TECHNOLOGIES IN THAT IT IS A WEARABLE DEVICE TOLERATED BY THE PATIENT, WORKS OVER MEDIUM-LARGE DISTANCES BOTH INDOORS AND OUTDOORS, WORKS EVEN IN THE ABSENCE OF A NETWORK CONNECTION, FULLY AUTOMATED AND EASY TO USE. BY 2025, AVANIX AIMS TO SELL 75,000 OIX CARE SYSTEMS WORLDWIDE AND GENERATE REVENUES OF ÂEUR 23.8 MILLION. AVANIX’S SOLUTION WILL SIGNIFICANTLY CONTRIBUTE TO THE WELFARE OF CAREGIVERS, AND TO AN ANNUAL COST SAVINGS RELATED TO THEIR ACTIVITY TO SUPPORT THE SICK. AFTER A TEST PHASE, AVANIX WILL START PRODUCTION OF OIX CARE IN THE FOURTH QUARTER OF 2019. AVA TEAM (English)
31 January 2022
0 references
SCANZOROSCIATE
0 references